Qiagen N.V. (QGEN) Q1 2026 Earnings Name April 28, 2026 9:30 AM EDT
Firm Individuals
Daniel Wendorff – VP & Head of Investor Relations
Thierry Bernard – CEO, MD & Member of Administration Board
Roland Sackers – CFO, MD & Member of Administration Board
Convention Name Individuals
Michael Ryskin – BofA Securities, Analysis Division
Tycho Peterson – Jefferies LLC, Analysis Division
Casey Woodring – JPMorgan Chase & Co, Analysis Division
Jack Meehan – Nephron Analysis LLC
Aisyah Noor – Morgan Stanley, Analysis Division
Douglas Schenkel – Wolfe Analysis, LLC
Odysseas Manesiotis – BNP Paribas, Analysis Division
Harry Gillis – Joh. Berenberg, Gossler & Co. KG, Analysis Division
Catherine Ramsey – Robert W. Baird & Co. Included, Analysis Division
Presentation
Operator
Women and gents, thanks for standing by. I’m Katie, your name operator. Welcome, and thanks for becoming a member of QIAGEN’s Preliminary Q1, 2026 Earnings Convention Name Webcast. [Operator Instructions] Please be suggested that this name is being recorded at QIAGEN’s request and will likely be made accessible on their Web web site. [Operator Instructions]
At the moment, I would prefer to introduce your host, Daniel Wendorff, Vice President, Head of Investor Relations at QIAGEN. Please go forward.
Daniel Wendorff
VP & Head of Investor Relations
Thanks, Katie, and welcome to our name on our preliminary outcomes for the primary quarter of 2026. In gentle of the replace to our 2026 outlook, the pre-announcement was issued in step with German disclosure necessities yesterday night. We’re planning to publish full Q1, 2026 outcomes on Could 6, 2026. We recognize your time and curiosity in QIAGEN.
Becoming a member of the decision right this moment are Thierry Bernard, our Chief Govt Officer; and Roland Sackers, our Chief Monetary Officer. Additionally becoming a member of us is Dr. Domenica Martorana from our Investor Relations staff. As at all times, right this moment’s name is being webcast dwell and will likely be archived within the Investor Relations part of our web site at www.qiagen.com, the place
